Showing results (711-720 of 1,096) with videos related to

Sort By:
Pageof 110
Human Pathology|November 18, 2018
Utility of JAK2 V617F allelic burden in distinguishing chronic myelomonocytic Leukemia from Primary myelofibrosis with monocytosisZhihong Hu, Carlos E Bueso Ramos, L Jeffrey Medeiros, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 2, 2020
Correction: Chronic myeloid leukemia with insertion-derived BCR-ABL1 fusion: redefining complex chromosomal abnormalities by correlation of FISH and karyotype predicts prognosisZhenya Tang, Gokce A Toruner, Guilin Tang, et al.
American Journal of Clinical Pathology|June 19, 2012
Rapid detection and quantitation of BRAF mutations in hairy cell leukemia using a sensitive pyrosequencing assayShalini Verma, Wesley O Greaves, Farhad Ravandi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2025
Phase 1 Evaluation of VH4524184, a Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance ProfileLuise Rogg, Mark Underwood, Nathan Hanan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2010
Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapyJack Phan, Ali Mazloom, L Jeffrey Medeiros, et al.
American Journal of Clinical Pathology|April 20, 2011
Chronic lymphocytic leukemia with t(14;19)(q32;q13) is characterized by atypical morphologic and immunophenotypic features and distinctive genetic featuresYang O Huh, Carmen D Schweighofer, Rhett P Ketterling, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 16, 2013
Differential expression of aurora-A kinase in T-cell lymphomasRashmi Kanagal-Shamanna, Norman L Lehman, James P O'Donnell, et al.
Archives of Pathology & Laboratory Medicine|May 1, 2013
Plasma cell enrichment enhances detection of high-risk cytogenomic abnormalities by fluorescence in situ hybridization and improves risk stratification of patients with plasma cell neoplasmsGary Lu, Ramya Muddasani, Robert Z Orlowski, et al.
Leukemia & Lymphoma|June 14, 2012
Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemiaSergej Konoplev, C Cameron Yin, Steven M Kornblau, et al.
Journal of Hematology & Oncology|June 10, 2015
Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patientsSanam Loghavi, Khaled Alayed, Tariq N Aladily, et al.
Pageof 110